Features of selective kinase inhibitors

被引：522

作者：

Knight, ZA ^{[1
]}

Shokat, KM ^{[1
]}

机构：

[1] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA

来源：

CHEMISTRY & BIOLOGY | 2005年 / 12卷 / 06期

关键词：

D O I：

10.1016/j.chembiol.2005.04.011

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Small-molecule inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction. Despite the widespread use of these reagents, there is little consensus about the biochemical criteria that define their potency and selectivity in cells. We discuss some of the features that determine the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.

引用

页码：621 / 637

页数：17

共 129 条

[1] PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues [J].

Abbott, BM ;

Thompson, PE .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (11) :2847-2851

[2] Chemical genetic analysis of Apg1 reveals a nonkinase role in the induction of autophagy [J].

Abeliovich, H ;

Zhang, C ;

Dunn, WA ;

Shokat, KM ;

Klionsky, DJ .

MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (02) :477-490

[3] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].

ALESSI, DR ;

CUENDA, A ;

COHEN, P ;

DUDLEY, DT ;

SALTIEL, AR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494

[4] Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I [J].

Arnold, LD ;

Calderwood, DJ ;

Dixon, RW ;

Johnston, DN ;

Kamens, JS ;

Munschauer, R ;

Rafferty, P ;

Ratnofsky, SE .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (19) :2167-2170

[5] Toward a pharmacophore for kinase frequent hitters [J].

Aronov, AM ;

Murcko, MA .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (23) :5616-5619

[6] On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells [J].

Arooz, T ;

Yam, CH ;

Siu, WY ;

Lau, A ;

Li, KKW ;

Poon, RYC .

BIOCHEMISTRY, 2000, 39 (31) :9494-9501

[7] The specificities of protein kinase inhibitors: an update [J].

Bain, J ;

McLauchlan, H ;

Elliott, M ;

Cohen, P .

BIOCHEMICAL JOURNAL, 2003, 371 :199-204

[8] Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors [J].

Barnett, SF ;

Defeo-Jones, D ;

Fu, S ;

Hancock, PJ ;

Haskell, KM ;

Jones, RE ;

Kahana, JA ;

Kral, AM ;

Leander, K ;

Lee, LL ;

Malinowski, J ;

McAvoy, EM ;

Nahas, DD ;

Robinson, RG ;

Huber, HE .

BIOCHEMICAL JOURNAL, 2005, 385 :399-408

[9] Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors [J].

Baxter, A ;

Brough, S ;

Cooper, A ;

Floettmann, E ;

Foster, S ;

Harding, C ;

Kettle, J ;

McInally, T ;

Martin, C ;

Mobbs, M ;

Needham, M ;

Newham, P ;

Paine, S ;

St-Gallay, S ;

Salter, S ;

Unitt, J ;

Xue, YF .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (11) :2817-2822

[10] Cloning and characterization of Xenopus Rsk2, the predominant p90 Rsk isozyme in oocytes and eggs [J].

Bhatt, RR ;

Ferrell, JE .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) :32983-32990

← 1 2 3 4 5 6 7 8 9 10 →